STOCKHOLDERS' EQUITY

6 Months Ended

Aug. 31, 2021

Equity [Abstract]

STOCKHOLDERS' EQUITY

NOTE 12 – STOCKHOLDERS’ EQUITY

Stock-based compensation expense is included in the following captions of the condensed consolidated statements of comprehensive loss (in thousands):

	Three Months Ended				Six Months Ended
	August 31,				August 31,
	2021		2020		2021		2020
Cost of revenues	$	795		165	$	789	$	308
Research and development		321		647		1,031		1,223
Selling and marketing		979		607		1,623		991
General and administrative		723		1,054		1,783		2,323
Restructuring		-		-				875
Other non-operating expense		119		-		183		-
	$	2,937	$	2,473	$	5,409	$	5,720

Changes in our outstanding stock options during the six months ended August 31, 2021 were as follows (options in thousands):

	Number of Options			Weighted Average Exercise Price		Weighted average remaining contractual life (years)		Aggregate intrinsic value
Outstanding at February 28, 2021		778		$	16.01		6.0
Granted		—			—
Exercised		(33	)		7.53
Forfeited or expired		(76	)		16.49
Outstanding at August 31, 2021		669		$	16.37		5.9	$	39
Exercisable at August 31, 2021		543		$	16.33		5.3	$	20

Changes in our outstanding restricted stock shares, performance stock units (“PSUs”) and restricted stock units (“RSUs”) during the six months ended August 31, 2021 were as follows (restricted shares, PSUs and RSUs in thousands):

	Number of Restricted Shares, PSUs and RSUs			Weighted Average Grant Date Fair Value		Shares Retained to Cover Statutory Minimum Withholding Taxes
Outstanding at February 28, 2021		3,053		$	10.61
Granted		1,235			12.27
Vested		(886	)		11.73		324
Forfeited		(282	)		10.70
Outstanding at August 31, 2021		3,120		$	10.92

As of August 31, 2021, there was $29.1 million of total unrecognized stock-based compensation cost related to outstanding nonvested equity awards that is expected to be recognized as an expense over a weighted-average remaining vesting period of 2.5 years.